Literature DB >> 25148272

Social impact of the burden of psoriasis: effects on patients and practice.

Steven R Feldman1, Mona Malakouti, John Ym Koo.   

Abstract

The raised, scaly, and erythematous plaques associated with psoriasis can be cosmetically disfiguring, which may provoke disgust, fear, and aversion in others. Consequently, the social stigma of psoriasis can be devastating for patients, evoking feelings of shame and anxiety about how they are perceived. In recent years, appreciation of psoriasis as a disease that can cause social distress and impairment has increased. This review discusses the manifold social burdens of psoriasis; different and emerging therapies that may mitigate these burdens by improving outcomes associated with the underlying disease; and psoriasis management in the context of healthcare reform changes focused on assessing the quality and value of patient care. The social impact of psoriasis is substantial (eg, affecting interpersonal relationships, sexual function, intimacy, occupational success). Undertreatment of psoriasis continues, despite evidence that biologic agents may lessen the physical and social burdens and provide greater patient satisfaction than conventional therapy. Changes in healthcare place an even greater emphasis on measurable outcomes, including patient satisfaction. Increased understanding of the social burden of psoriasis may lead to provision of more comprehensive, holistic care that is in concordance with the evolving restructured reimbursement system.

Entities:  

Mesh:

Year:  2014        PMID: 25148272

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  17 in total

1.  Secukinumab.

Authors:  Dennis J Cada; Danial E Baker; Shannon G Panther; Kyle Ingram PharmD
Journal:  Hosp Pharm       Date:  2015-09-16

2.  An Analysis of Patient-reported Outcomes in IXORA-S: Comparing Ixekizumab and Ustekinumab over 52 Weeks in Moderate-to-severe Psoriasis.

Authors:  Lluís Puig; Mark Lomaga; Kristin Hollister; Yves Dutronc; Lovisa Berggren; Peter C M van de Kerkhof
Journal:  Acta Derm Venereol       Date:  2020-12-09       Impact factor: 3.875

3.  Relationship Between Skin Shame, Psychological Distress and Quality of Life in Patients with Psoriasis: a Pilot Study.

Authors:  Donja Homayoon; Michaela Hiebler-Ragger; Moritz Zenker; Wolfgang Weger; Human Unterrainer; Elisabeth Aberer
Journal:  Acta Derm Venereol       Date:  2020-07-02       Impact factor: 3.875

4.  Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis.

Authors:  Mingliang Zhang; Susan K Brenneman; Chureen T Carter; Breanna L Essoi; Kamyar Farahi; Michael P Johnson; Seina Lee; William H Olson
Journal:  Patient Prefer Adherence       Date:  2015-06-16       Impact factor: 2.711

Review 5.  Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials.

Authors:  Benjamin Farahnik; Kourosh Beroukhim; Tian Hao Zhu; Michael Abrouk; Mio Nakamura; Rasnik Singh; Kristina Lee; Tina Bhutani; John Koo
Journal:  Dermatol Ther (Heidelb)       Date:  2016-02-24

Review 6.  The Patient's Guide to Psoriasis Treatment. Part 2: PUVA Phototherapy.

Authors:  Benjamin Farahnik; Mio Nakamura; Rasnik K Singh; Michael Abrouk; Tian Hao Zhu; Kristina M Lee; Margareth V Jose; Renee DaLovisio; John Koo; Tina Bhutani; Wilson Liao
Journal:  Dermatol Ther (Heidelb)       Date:  2016-07-29

Review 7.  Treatment challenges in the management of moderate-to-severe plaque psoriasis - role of secukinumab.

Authors:  Mona Malakouti; Sharon E Jacob; Nancy J Anderson
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-10-11

Review 8.  Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials.

Authors:  Benjamin Farahnik; Kourosh Beroukhim; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Rasnik Singh; Kristina Lee; Tina Bhutani; John Koo
Journal:  Dermatol Ther (Heidelb)       Date:  2016-05-25

9.  Psychopathological Variables and Sleep Quality in Psoriatic Patients.

Authors:  Maria Luca; Antonina Luca; Maria Letizia Musumeci; Federica Fiorentini; Giuseppe Micali; Carmela Calandra
Journal:  Int J Mol Sci       Date:  2016-07-21       Impact factor: 5.923

Review 10.  Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability.

Authors:  Benjamin Farahnik; Viraat Patel; Kourosh Beroukhim; Tian Hao Zhu; Michael Abrouk; Mio Nakamura; Rasnik Singh; Kristina Lee; Tina Bhutani; John Koo
Journal:  Psoriasis (Auckl)       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.